Markets:

Overview

News

Currencies

International

Treasuries

Astrana Health Inc. - Common Stock (NQ:ASTH)

21.10 -0.61 (-2.81%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Astrana Health Inc. - Common Stock

< Previous 1 2 3 Next >

1 Profitable Stock with Solid Fundamentals and 2 to Steer Clear Of

April 23, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers

April 17, 2025

Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.

Via StockStory

Q4 Rundown: Astrana Health (NASDAQ:ASTH) Vs Other Healthcare Technology for Providers Stocks

April 16, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) and its peers.

Via StockStory

Medicare Advantage Rates Expected To Climb Over 5% In 2026, Easing Pressure On Managed Care ↗

April 08, 2025

CMS raises 2026 Medicare Advantage payments by 5.06%, exceeding projections and benefiting insurers focused on value-based care.

Via Benzinga

What 4 Analyst Ratings Have To Say About Astrana Health ↗

March 04, 2025

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

Demystifying Astrana Health: Insights From 3 Analyst Reviews ↗

November 13, 2024

Via Benzinga

Assessing Astrana Health: Insights From 6 Financial Analysts ↗

April 01, 2025

Via Benzinga

2 Healthcare Stocks with Solid Fundamentals and 1 to Turn Down

March 31, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

2 Reasons to Like ASTH and 1 to Stay Skeptical

March 18, 2025

What a brutal six months it’s been for Astrana Health. The stock has dropped 47.7% and now trades at $29.91, rattling many shareholders. This may have investors wondering how to approach the...

Via StockStory

Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR)

March 14, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Phreesia (NYSE:PHR) and its peers.

Via StockStory

What 5 Analyst Ratings Have To Say About Astrana Health ↗

October 03, 2024

Via Benzinga

Analyst Scoreboard: 5 Ratings For Astrana Health ↗

August 01, 2024

Via Benzinga

1 Stock Under $50 with Solid Fundamentals and 2 to Turn Down

March 13, 2025

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Via StockStory

Phreesia (PHR) To Report Earnings Tomorrow: Here Is What To Expect

March 11, 2025

Healthcare technology company Phreesia (NYSE:PHR) will be reporting results tomorrow after the bell. Here’s what to look for.

Via StockStory

Why Astrana Health (ASTH) Shares Are Sliding Today

February 28, 2025

Shares of healthcare services company Astrana Health fell 31.9% in the afternoon session after the company reported weak fourth quarter results, its full-year EBITDA guidance missed significantly and...

Via StockStory

Friday's session: top gainers and losers ↗

February 28, 2025

Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

These stocks are gapping in today's session ↗

February 28, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.

Via Chartmill

Astrana Health’s (NASDAQ:ASTH) Q4 Sales Beat Estimates

February 27, 2025

Healthcare services company Astrana Health announced better-than-expected revenue in Q4 CY2024, with sales up 88.4% year on year to $665.2 million. The company expects the full year’s revenue to be...

Via StockStory

Topics Earnings

Astrana Health (ASTH) To Report Earnings Tomorrow: Here Is What To Expect

February 26, 2025

Healthcare services company Astrana Health will be reporting results tomorrow afternoon. Here’s what investors should know.

Via StockStory

Analyst Sees Pent-Up Demand Impact On Astrana Health's Value-Based Care Model ↗

July 11, 2024

Truist Securities upgraded Astrana Health due to its strong performance in value-based care industry.

Via Benzinga

Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 11, 2024

Via Benzinga

Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday ↗

July 11, 2024

Via Benzinga

Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday ↗

July 11, 2024

Via Benzinga

ASTH Stock Earnings: Astrana Health Beats EPS, Misses Revenue for Q1 2024 ↗

May 28, 2024

ASTH stock results show that Astrana Health beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Truist Securities Maintains Hold Rating for Astrana Health: Here's What You Need To Know ↗

March 01, 2024

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Astrana Health Inc. - Common Stock (NQ:ASTH)

All News about Astrana Health Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today